The Global market for Clinical Trial Management System is expected to reach $2 billion by the end of 2020 growing at a CAGR of around 12.5% from 2014 to 2021. Clinical Trial Management System is a system used by pharmaceutical and biotechnology industries to manage clinical trials in clinical research.
The systems comprises of protocol development, site selection and trial preparation, subject identification & enrollment, collection, monitoring & processing of data, data analysis and reporting, pharmacovigilance and submission for review. Data is collected during the process of trials and is stored in the database. The data is then reviewed to decide upon the safety parameters of the drug.
The Global Clinical Trial Management System Market is segmented on the basis of Delivery Mode (Web based Clinical Trial Management System, On Premise Clinical Trial Management System and Cloud based Clinical Trial Management System), Components (Software, Hardware and Services), End User (Pharmaceuticals & Biotechnology Companies and Healthcare Providers: Research Hospitals, Clinics, Academic Medical Centres and Cancer Centres), Type (Site based Clinical Trial Management System and Licensed Enterprise based Clinical Trial Management System), Applications (Patient Management Solutions, Site Management Solutions, Data Management Solutions and Document Management Solutions) and Region (North America, Europe, Asia Pacific and Rest of the World).
Rise in the number of clinical trials performed, Increasing incidences of chronic diseases, Increase in R&D to implement localized research programs and Synchronization of Hospital Information System (HIS) with CTMS are some of the factors driving the market growth.
Data security issues, Lack of qualified and skilled labor to handle CTMS and Huge cost of customized CTMS are some of the reasons hindering the growth of the market.
What the report offers:
Market Definition for the specified topic along with identification of key drivers and restraints for the market.
Market analysis for the Global ECG Market, with region specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.
Identification and analysis of the Macro and Micro factors that affect the Global ECG Market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
Manager – Partner Relations & International Marketing
Ph: +1-214-377-1121 (US)/ +44-020-3286-9338 (UK)